Mark Bailey - Publications

Eli Lilly & Company 

4 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Lu Y, Zhang Y, Cao X, Wang C, Wang Y, Zhang M, Ferrier RC, Jenkins A, Yuan J, Bailey MJ, Chen D, Tian H, Li H, von Weizsäcker EU, Zhang Z. Forty years of reform and opening up: China's progress toward a sustainable path. Science Advances. 5: eaau9413. PMID 31457075 DOI: 10.1126/sciadv.aau9413  0.6
2017 Sinnett SE, Hector RD, Gadalla KKE, Heindel C, Chen D, Zaric V, Bailey MES, Cobb SR, Gray SJ. Improved MECP2 Gene Therapy Extends the Survival of MeCP2-Null Mice without Apparent Toxicity after Intracisternal Delivery. Molecular Therapy. Methods & Clinical Development. 5: 106-115. PMID 28497072 DOI: 10.1016/j.omtm.2017.04.006  0.6
2008 Bailey MR, Chen D, Emery WR, Lambooy PK, Nolting J, Quertinmont MT, Shamlou PA. Evaluation of microfluidics reactor technology on the kinetics of virus inactivation. Biotechnology and Bioengineering. 99: 1384-91. PMID 18023056 DOI: 10.1002/bit.21714  0.6
2007 Zhao X, Bailey MR, Emery WR, Lambooy PK, Chen D. Evaluation of viral removal by nanofiltration using real-time quantitative polymerase chain reaction. Biotechnology and Applied Biochemistry. 47: 97-104. PMID 17233631 DOI: 10.1042/BA20060195  0.6
Show low-probability matches.